Morgan Stanley Affirms Overweight Rating on BUD APAC Following Stronger-Than-Expected Q1 Results

Stock News05-06

Morgan Stanley has issued a research report indicating that BUD APAC (01876) reported first-quarter revenue of $1.49 billion, a decline of 0.7% year-on-year, primarily due to a slight 0.1% increase in volume and a minor drop in average selling price. This figure exceeded the firm's forecast of $1.45 billion. During the period, the Indian market demonstrated robust performance, while the decline in the Chinese market narrowed. The bank maintained an "Overweight" rating with a target price of HK$9.

Normalized EBITDA for BUD APAC fell 8.1% year-on-year to $463 million in the first quarter, surpassing the bank's estimate of $457 million. The normalized EBITDA margin decreased by 246 basis points to 31%. Gross margin edged up by 1 basis point, while the EBIT margin dropped by 164 basis points year-on-year.

Looking ahead, the bank anticipates continued improvement in the company's EBITDA growth, driven mainly by a recovery in South Korean volume on a normalized base and year-on-year margin enhancement in the Chinese market.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment